The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Akebia Therapeutics
AKBA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.40
-0.02
-1.43%
At close: Jul 29, 6:21 PM EDT
$1.38
-0.02
-1.43%
After Hours: 6:21 PM EDT
15 minutes delayed
Get Report
Comment
Akebia Therapeutics (AKBA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Akebia Therapeutics (NASDAQ:AKBA) Stock
Akebia Therapeutics Stock (NASDAQ: AKBA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Akebia And CSL Vifor Have Terminated The Lice...
Benzinga Newsdesk
Monday, June 24, 2024
Akebia Therapeutics Announced Erik Ostrowski ...
Benzinga Newsdesk
Thursday, May 09, 2024
Akebia Therapeutics shares are trading lower ...
Benzinga Newsdesk
Akebia Therapeutics Q1 2024 GAAP EPS $(0.09) ...
Benzinga Newsdesk
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Friday, March 29, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Thursday, March 28, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Akebia T...
Benzinga Newsdesk
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
Vandana Singh
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Akebia Therapeutics shares are trading higher...
Benzinga Newsdesk
Reported Earlier, Akebia's Wins FDA Approval ...
Benzinga Newsdesk
Wednesday, March 27, 2024
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Tuesday, March 26, 2024
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Friday, March 15, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Akebia ...
Benzinga Newsdesk
Thursday, March 14, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Recap: Akebia Therapeutics Q4 Earnings
Benzinga Insights
Akebia Therapeutics Q4 Sales $56.200M Beat $5...
Benzinga Newsdesk
Earnings Scheduled For March 14, 2024
Benzinga Insights
Wednesday, March 13, 2024
Earnings Preview For Akebia Therapeutics
Benzinga Insights
Tuesday, January 30, 2024
Akebia Secures $55M Term Loan Financing
Benzinga Newsdesk
Wednesday, November 29, 2023
BTIG Assumes Akebia Therapeutics at Buy, Anno...
Benzinga Newsdesk
Friday, November 17, 2023
HC Wainwright & Co. Maintains Buy on Akebia T...
Benzinga Newsdesk
Wednesday, November 08, 2023
Akebia Therapeutics Reaffirms FY23 Net Produc...
Benzinga Newsdesk
Akebia Therapeutics Q3 EPS $(0.08), Inline, S...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Tuesday, November 07, 2023
Earnings Outlook For Akebia Therapeutics
Benzinga Insights
Wednesday, October 25, 2023
Akebia Receives FDA Acceptance Of Resubmissio...
Benzinga Newsdesk
Thursday, September 28, 2023
Akebia Therapeutics Resubmits New Drug Applic...
Benzinga Newsdesk
Wednesday, September 27, 2023
HC Wainwright & Co. Reiterates Buy on Akebia ...
Benzinga Newsdesk
Tuesday, September 26, 2023
Akebia Lowered Auryxia Product Revenue Guidan...
Benzinga Newsdesk
Australia's Therapeutic Goods Administration ...
Benzinga Newsdesk
Monday, August 28, 2023
Analyst Highly Confident In Akebia Therapeutics' Kidney Disease-Associated Anemia Drug, Stock Soars
Vandana Singh
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Benzinga Insights
HC Wainwright & Co. Upgrades Akebia Therapeut...
Benzinga Newsdesk
Friday, August 25, 2023
Akebia Has Affirmed Its 2023 Auryxia Net Prod...
Benzinga Newsdesk
Akebia Therapeutics Q2 EPS $(0.06) Misses $(0...
Benzinga Newsdesk
Earnings Scheduled For August 25, 2023
Benzinga Insights
Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday
Lisa Levin
Fear & Greed Index Moves To 'Fear' Zone Ahead Of Powell's Speech
Lisa Levin
Thursday, August 24, 2023
Earnings Outlook For Akebia Therapeutics
Benzinga Insights
Akebia Therapeutics Expects To Resubmit Vadad...
Benzinga Newsdesk
Friday, August 11, 2023
Akebia Therapeutics shares are trading lower ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Ake...
Benzinga Newsdesk
Thursday, August 10, 2023
Akebia Expects To Resubmit NDA For Vadadustat...
Benzinga Newsdesk
Akebia Therapeutics Reports Late Filing Of It...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch